These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11241875)

  • 1. Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI.
    Kimberg DY; Aguirre GK; Lease J; D'Esposito M
    Hum Brain Mapp; 2001 Apr; 12(4):246-57. PubMed ID: 11241875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1- versus D2-receptor modulation of visuospatial working memory in humans.
    Müller U; von Cramon DY; Pollmann S
    J Neurosci; 1998 Apr; 18(7):2720-8. PubMed ID: 9502829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype.
    Furman DJ; White RL; Naskolnakorn J; Ye J; Kayser A; D'Esposito M
    J Cogn Neurosci; 2020 May; 32(5):804-821. PubMed ID: 31905090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociable fronto-striatal effects of dopamine D2 receptor stimulation on cognitive versus motor flexibility.
    Stelzel C; Fiebach CJ; Cools R; Tafazoli S; D'Esposito M
    Cortex; 2013; 49(10):2799-811. PubMed ID: 23660437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients.
    McDowell S; Whyte J; D'Esposito M
    Brain; 1998 Jun; 121 ( Pt 6)():1155-64. PubMed ID: 9648550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory.
    Gibbs SE; D'Esposito M
    Psychopharmacology (Berl); 2005 Aug; 180(4):644-53. PubMed ID: 16001111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of D1 and D2 dopamine agonists on memory, motivation, learning and response time in non-human primates.
    Marino RA; Levy R
    Eur J Neurosci; 2019 Jan; 49(2):199-214. PubMed ID: 30326151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential dopaminergic modulation of executive control in healthy subjects.
    Roesch-Ely D; Scheffel H; Weiland S; Schwaninger M; Hundemer HP; Kolter T; Weisbrod M
    Psychopharmacology (Berl); 2005 Apr; 178(4):420-30. PubMed ID: 15765257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans.
    Bartholomeusz CF; Box G; Van Rooy C; Nathan PJ
    J Psychopharmacol; 2003 Mar; 17(1):9-15. PubMed ID: 12680735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine.
    Gelao B; Fazio L; Selvaggi P; Di Giorgio A; Taurisano P; Quarto T; Romano R; Porcelli A; Mancini M; Masellis R; Ursini G; De Simeis G; Caforio G; Ferranti L; Lo Bianco L; Rampino A; Todarello O; Popolizio T; Blasi G; Bertolino A
    Psychopharmacology (Berl); 2014 Jun; 231(11):2361-70. PubMed ID: 24424781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.
    Vernaleken I; Buchholz HG; Kumakura Y; Siessmeier T; Stoeter P; Bartenstein P; Cumming P; Gründer G
    Hum Brain Mapp; 2007 Oct; 28(10):931-9. PubMed ID: 17133402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopaminergic D2-like receptor stimulation upon behavioral and neural correlates of renewal depend on individual context processing propensities.
    Lissek S; Glaubitz B; Klass A; Tegenthoff M
    Neuroimage; 2018 Apr; 169():69-79. PubMed ID: 29242106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.
    Mehta MA; Swainson R; Ogilvie AD; Sahakian J; Robbins TW
    Psychopharmacology (Berl); 2001 Dec; 159(1):10-20. PubMed ID: 11797064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variation of a DRD2 Co-expression Network is Associated with Changes in Prefrontal Function After D2 Receptors Stimulation.
    Selvaggi P; Pergola G; Gelao B; Di Carlo P; Nettis MA; Amico G; Fazio L; Rampino A; Sambataro F; Blasi G; Bertolino A
    Cereb Cortex; 2019 Mar; 29(3):1162-1173. PubMed ID: 29415163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cortical dopamine D1 receptor binding associated with cognitive training.
    McNab F; Varrone A; Farde L; Jucaite A; Bystritsky P; Forssberg H; Klingberg T
    Science; 2009 Feb; 323(5915):800-2. PubMed ID: 19197069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation.
    Gibbs SE; D'Esposito M
    Cogn Affect Behav Neurosci; 2005 Jun; 5(2):212-21. PubMed ID: 16180627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
    Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Kanki R; Yamashita H; Akaike A
    J Neurosci Res; 2002 Nov; 70(3):274-82. PubMed ID: 12391586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
    Franken IH; Nijs I; Pepplinkhuizen L
    Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cognitive flexibility depends on dopamine D2 receptor signaling.
    van Holstein M; Aarts E; van der Schaaf ME; Geurts DE; Verkes RJ; Franke B; van Schouwenburg MR; Cools R
    Psychopharmacology (Berl); 2011 Dec; 218(3):567-78. PubMed ID: 21611724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.